Modern views on erectile dysfunction and new methods for its treatment
Abstract
About 150 million men worldwide suffer from erectile dysfunction (ED). In the next 25 years, this figure could double. High ED prevalence is explained not only by ageing problems, but also by increased prevalence of diseases and taking medications, causing sexual dysfunction. Therefore, ED is not only a factor determining male quality of life, but also one of the principal social parameters of the health care system in general.
About the Authors
A. L. Vertkin
Moscow State Medico-Stomatological University, Moscow
Russian Federation
Russian Federation
D. Yu. Pushkar
Moscow State Medico-Stomatological University, Moscow
Russian Federation
Russian Federation
D. Z. Dolaberidze
Moscow State Medico-Stomatological University, Moscow
Russian Federation
Russian Federation
Yu. S. Polupanova
Moscow State Medico-Stomatological University, Moscow
Russian Federation
Russian Federation
References
1. Пушкарь Д.Ю., Тевлин К.П., Сидоров Д.В. Эректильная дисфункция: принципы диагностики и новое в медикаментозном лечении. Фарматека 2002; 10: 61-8.
2. Лоран О.Б., Щеплев П.А., Нестеров С.Н. и др. Современные методы диагностики и лечения эректильной дисфункции. РМЖ 2000; 8: 130-4.
3. Nusbaum MR. Erectile dysfunction: prevalence, etiology, and major risk factors. J Am Osteopath Assoc 2002; 102(12Supple 4): S1-6.
4. Kroner BA, Mulligan T, Briggs GC. Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study. Ann Pharmacother 1993; 27: 1329-32.
5. Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dusfunction. J Urol 2000; 164: 1188-91.
6. Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-6.
7. Kloner RA, Watkins VS, Costigan TM, et al. Cardiovascular profile of tadalafil. a new PDE5 inhibitor. J Urol 2002; 167(4): 176.
8. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common demominator. Heart 2003; 89(3): 251-3.
9. Kochar MS, Mazur LI, Patel A. What is causing your patient’s sexual dysfunction? Uncovering a connection with hypertension and antihypertensive therapy. Postgrad Med 1999; 106(2): 149- 52, 155-7.
10. Fogari R, Zoppi A, Corradi L, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 2002; 1244-7.
11. Jackson G. Sexual intercourse and stable angina pectoria. Am J Cardiol 2000; 86(2A): 35F-7.
12. Kung CF, Luscher TF. Different medhanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995; 25: 194-200.
13. Bedell SE, Duperval M, Goldberg R. Cardiologists’ discussions about sexuality with patients with chronic coronary artery disease. Am Heart J 2002; 144(2): 239-42.
14. Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinik outpatients. JAMA 1983; 249: 1736-40.
15. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27-31.
16. Rosen RC, Kostis JB, Jekelis A, et al. Sexual sequelae of antihypertensive drugs: treatment effects on self-report and physiological measures in middle-aged male hypertensives. Arch Sex Behav 1994; 23(2): 135-52.
17. Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinik outpatients. JAMA 1983; 249; 1736-40.
18. DeBusk R, Drory Y, Goldstein I, et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86(2A): 62F-8.
19. Muller JE, Mitteman A, Maclure M, et al. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA 1996; 275: 415-34.
20. Muller JE, Mittleman A, Maclure M, et al. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA 1996; 275: 1405-9.
21. Krauland W. Underwarteter Tod: Herzinfarkt und Sexualitat aus der Sicht des Rechtsmediziners [Myocardial infarction and sexuality from the coroner’s point of view]. Sexualmedezin 1976; 10: 20-3.
22. Persson G. Five – year mortality in a 70 – year – old urban population in relation to psychiatric diagnosis, personality, sexuality am early parental death. Acta Psychiatr. Scand 1981; 64: 244-53.
23. Smith DG, Frankel S, Yamell J. Sex and death: are they related? Findings from the Caerphilly Cohort Study. BMJ 1997; 315: 1641-4.
24. Brock G, McMahon C, Chen K, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168(4, pt 1): 1332-6.
25. Padma-Nathan H, Rosen R, Shabsigh R, et al. Tadalafil (IC351) provides prompt response and extended period of responsiveness for the treatment of men with erectile dysfunction (ED). Lnt J Impot Res 2001; 3(Suppl 4): S33.
26. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288(3): 351-7.
27. Prisant LM. Fixed low-dose combination in first-line treatment of hypertension. J Hypertens 2002; 20(Suppl 1): S11-9.
28. Fogari R, Corradi I, Poletti L, et al. Sexual activity in hypertensive males treated with valsartan or carvedilol. A cross-over study. J of Hypertens 1999; 17(Suppl. 3): S 65.
29. Llisterri JL, Lozano Vidal JV, Vicente AJ, et al. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001; 321(5): 336-41.
30. Marley JE. Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice. J R Soc Med 1989; 82(5): 272-5.
31. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ 2000; 321(19): 499-503.
32. Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995; 75: 835-7.
33. Jachuck SJ, Brierley H, Jachuck S, Willcox PM. The effect of hypertensive drugs on quality of life. J R Coll Gen Pract 1982; 32(235): 103-5.
34. Wespes E, Amar E, Hatzichristou D, et al. Guidelines on erecrile dysfunction. Eur Urol 2002; 42(1): 1-5.
35. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 1997; 49(6): 822-30.
Review
For citations:
Vertkin A.L., Pushkar D.Yu., Dolaberidze D.Z., Polupanova Yu.S. Modern views on erectile dysfunction and new methods for its treatment. Cardiovascular Therapy and Prevention. 2005;4(3, ч.II):101-112. (In Russ.)
Views:
611
Email this article 
